Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	30.46	47.23	36.20
Graham Fair Price	-3.00	165.63	170.76
PEG	244.39	-4.00	1.16
Price/Book	23.52	5.49	4.45
Price/Cash Flow	35.87	74.73	55.00
Prices/Earnings	45.08	22.14	15.26
Price/Sales	37.04	33.69	24.58
Price/FCF	35.87	74.73	55.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.06	0.53	0.53
Operating Margin	1.09	0.42	0.42
ROA	-14.46	0.04	0.05
ROE	0.07	0.06	-14.86
ROIC	0.05	0.05	-10.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.04	17.45
Dividends QOQ	0.09	< 0.005	-99.91
EBIT QOQ	0.14	-0.04	-69.94
EPS QOQ	0.13	-0.06	-57.87
FCF QOQ	3.18	-0.04	-98.61
Revenue QOQ	0.14	-0.05	-63.52
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.90	86.44	12.40
Days Sales Outstanding (DSO)	29.06	30.69	5.57
Inventory Turnover	1.17	1.04	-11.03
Debt/Capitalization	0.21	0.21	0.25
Quick Ratio	2.07	2.07	0.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	133.38	140.21	5.12
Cash	65.08	74.15	13.93
Capex	-4.81	-7.07	-46.98
Free Cash Flow	10.78	10.30	-4.43
Revenue	24.12	22.86	-5.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.40	2.39	-0.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.23	-1.69	-36.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating